Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.
Cancer can be envisioned as a metabolic disease driven by pressure selection and intercellular cooperativeness. Together with anaerobic glycolysis, the Warburg effect, formally corresponding to uncoupling glycolysis from oxidative phosphorylation, directly participates in cancer aggressiveness, supp...
Main Authors: | Christophe J De Saedeleer, Tamara Copetti, Paolo E Porporato, Julien Verrax, Olivier Feron, Pierre Sonveaux |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23082126/pdf/?tool=EBI |
Similar Items
-
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.
by: Pierre Sonveaux, et al.
Published: (2012-01-01) -
Lactate does not activate NF-κB in oxidative tumor cells
by: Vincent F Van Hée, et al.
Published: (2015-10-01) -
A Mitochondrial Switch Promotes Tumor Metastasis
by: Paolo E. Porporato, et al.
Published: (2014-08-01) -
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review
by: Paolo E Porporato, et al.
Published: (2011-08-01) -
Lactate and Cancer: Revisiting the Warburg Effect in an Era of Lactate Shuttling
by: Matthew Lawrence Goodwin, et al.
Published: (2015-01-01)